M. Bratová (Brno 35, Czech Republic), P. Denniston (London, United Kingdom)
Microbiological analysis and empirical antibiotic preference in complicated pleural infections
E. Yavuzsan (Istanbul, Turkey), F. Tokgöz Akyil (Istanbul, Turkey), S. Tural Önür (Istanbul, Turkey), M. Dogru (Istanbul, Turkey), L. Cansever (Istanbul, Turkey), S. Altin (Istanbul, Turkey)
|  |
The microbiology of adult pleural infection in an Egyptian hospital
M. Hassan (Alexandria, Egypt), M. Gadallah (Alexandria, Egypt), A. Elshazly (Alexandria, Egypt), B. El-Shaarawy (Alexandria, Egypt), A. Sadaka (Alexandria, Egypt)
|  |
Ambulatory management of bronchopleural fistulae secondary to empyema
J. Davy (Ipswich, United Kingdom), P. Tang (Ipswich, United Kingdom), M. Burton (Ipswich, United Kingdom)
| |
Nursing administration of Alteplase and Dornase Alfa in empyema
H. Shah (Gateshead, United Kingdom), T. Fretwell (Gateshead, United Kingdom), G. Stiller (Gateshead, United Kingdom), S. Bain (Gateshead, United Kingdom)
| |
USE AND EFFECTIVENESS OF INTRAPLEURAL FIBRINOLYTICS IN COMPLICATED PARAPNEUMONIC EFFUSIONS AND EMPYEMAS
F. Sampsonas (Patra, Greece), M. Lagadinou (Patra, Greece), . Mpouga (Patra, Greece), I. Picliknski (Patra, Greece), T. Karampitsakos (Patra, Greece), O. Papaioannou (Patra, Greece), M. Katsaras (Patra, Greece), P. Tsiri (Patra, Greece), G. Tsirikos (Patra, Greece), E. Zarkadi (Patra, Greece), V. Sotiropoulou (Patra, Greece), A. Tzouvelekis (Patra, Greece)
| |
A feasibility randomised trial comparing therapeutic thoracentesis to chest tube insertion for the management of pleural infection: results from the ACTion trial.
D. Arnold (Bristol, United Kingdom), E. Tucker (Bristol, United Kingdom), A. Morley (Bristol, United Kingdom), A. Milne (Bristol, United Kingdom), L. Stadon (Bristol, United Kingdom), S. Patole (Bristol, United Kingdom), G. Nava (Bristol, United Kingdom), S. Walker (Bristol, United Kingdom), N. Maskell (Bristol, United Kingdom)
| |
Management and outcomes of patients with pleural empyema
N. Kallel (Sfax, Tunisia), M. Abdelkefi (Sfax, Tunisia), A. El Euch (Sfax, Tunisia), M. Hamoudi (Sfax, Tunisia), S. Abid (Sfax, Tunisia), W. Feki (Sfax, Tunisia), S. Kammoun (Sfax, Tunisia)
| |
Lung abscess is associated with COPD, use of sedatives and a high mortality: A retrospective cohort study
J. Kirkegaard Vaarst (Aarhus N, Denmark), S. Sperling Haugen (Aarhus N, Denmark), V. Dahl (Aarhus N, Denmark), A. Fløe Hvass (Aarhus N, Denmark), C. Borbjerg Laursen (Odense, Denmark), E. Bendstrup (Aarhus N, Denmark), S. Sperling (Aarhus N, Denmark)
| |
Lung hydatidosis treatment: which are the associated morbidity and mortality risk factors ?
Z. Chaari (Sfax, Tunisia), A. Hentati (Sfax, Tunisia), A. Ben Ayed (Sfax, Tunisia), W. Abid (Sfax, Tunisia), I. Frikha (Sfax, Tunisia)
| |
An unusual cause of infection in immunocompetent individuals: A case series
D. Mascarenhas (Hyderabad, India), H. Gonuguntla (Hyderabad, India), R. Kumar (Hyderabad, India), P. Vidyasagar (Hyderabad, India), S. Reddy (Hyderabad, India), S. Syeda (Hyderabad, India)
| |
Valaciclovir for Epstein-Barr virus suppression in Chronic Obstructive Pulmonary Disease: A Randomised Controlled Trial (EViSCO)
D. Linden (Belfast, United Kingdom), H. Guo-Parke (Belfast, United Kingdom), M. Mckelvey (Belfast, United Kingdom), G. Einarsson (Belfast, United Kingdom), A. Lee (Belfast, United Kingdom), D. Fairley (Belfast, United Kingdom), V. Brown (Belfast, United Kingdom), D. Logan (Belfast, United Kingdom), C. Campbell (Belfast, United Kingdom), D. Singh (Manchester, United Kingdom), M. Tunney (Belfast, United Kingdom), D. Mcauley (Belfast, United Kingdom), C. Taggart (Belfast, United Kingdom), J. Kidney (Belfast, United Kingdom)
| |
Pulmonary hydatid disease: clinical and radiographic features
A. Ezzaouia (Tunis, Tunisia), I. Akrout (Tunis, Tunisia), H. Kamoun (Tunis, Tunisia), A. Ben Mansour (Tunis, Tunisia), H. Hassene (Tunis, Tunisia), Y. Bellil (Tunis, Tunisia), H. Ouertani (Tunis, Tunisia), H. Rejeb (Tunis, Tunisia), D. Greb (Tunis, Tunisia), H. Smadhi (Tunis, Tunisia), H. Ben Abdelghaffar (Tunis, Tunisia), L. El Fekih (Tunis, Tunisia), M. Megdiche (Tunis, Tunisia)
| |
Pulmonary infection characteristics leading to respiratory failure, a modelling approach.
B. Mauroy (Nice, France), F. Noël (Nice, France), F. NOEL (Paris, France)
| |
Tolerance and safety of inhaled hypertonic saline solutions in patients with chronic bronquial infection.
D. Velasco Álvarez (Madrid, Spain), D. Durán Barata (Madrid, Spain), R. Nieto Royo (Madrid, Spain), R. Morillo Guerrero (Madrid, Spain), A. Solier López (Madrid, Spain), C. Almonacid Sánchez (Castilla-La Mancha, Spain), E. Barbero Herranz (Madrid, Spain), B. Pintado Cort (Madrid, Spain), A. Pérez Figuera (Madrid, Spain), L. Máiz Carro (Madrid, Spain)
| |
The contribution of bronchoscopy in the diagnosis of pulmonary hydatid cyst
Z. Laklaai (casablanca, Morocco), K. Channoune (casablanca, Morocco), N. Zaghba (casablanca, Morocco), H. Benjelloune (casablanca, Morocco), N. Yassine (casablanca, Morocco)
| |
Human tularemia in Southern Germany: a case series
M. Vacca (Gauting, Germany), M. Heiß-Neumann (Gauting, Germany)
| |
Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea in hospitalized adult patients with lower respiratory tract infections
B. Milenkovic (Beograd, Republic of Serbia), I. Andrijevic (Novi Sad, Republic of Serbia), S. Dimic Janjic (Beograd, Republic of Serbia), S. Milutinov Ilic (Novi Sad, Republic of Serbia), I. Kopitovic (Novi Sad, Republic of Serbia), M. Stjepanovic (Beograd, Republic of Serbia), A. Andrijevic (Novi Sad, Republic of Serbia), J. Jankovic (Beograd, Republic of Serbia), S. Mitrovic (Beograd, Republic of Serbia)
| |
Bacterial biofilms predominate in both acute and chronic human lung infections
M. Kolpen (Copenhagen, Denmark), K. Kragh (Copenhagen, Denmark), J. Enciso (Atanta, United States), D. Faurholt-Jepsen (Copenhagen, Denmark), B. Lindegaard (Hillerød, Denmark), G. Egelund (Hillerød, Denmark), A. Jensen (Hillerød, Denmark), P. Ravn (Hellerup, Denmark), I. Mathiesen (Copenhagen, Denmark), A. Gheorghe (Copenhagen, Denmark), F. Hertz (Herlev, Denmark), T. Qvist (Copenhagen, Denmark), M. Whiteley (Atlanta, United States), P. Jensen (Copenhagen, Denmark), T. Bjarnsholt (Copenhagen, Denmark)
| |
Pleuropneumonia caused by Nocardia cyriacigeorgica in a 14-year-old girl with PCD
R. Urbantat (Berlin, Germany), C. Pioch (Berlin, Germany), N. Ziegahn (Berlin, Germany), M. Stegemann (Berlin, Germany), M. Stahl (Berlin, Germany), M. Mall (Berlin, Germany), J. Röhmel (Berlin, Germany)
| |
Integrated microbiome-mucus profiling in chronic obstructive pulmonary disease (COPD)
O. Meldrum (Singapore, Singapore), G. Donaldson (London, United Kingdom), P. Tiew (Singapore, Singapore), H. Xu (Singapore, Singapore), J. Narayana (Singapore, Singapore), F. Ivan (Singapore, Singapore), T. Jaggi (Singapore, Singapore), M. Aogáin (Singapore, Singapore), J. Abisheganaden (Singapore, Singapore), J. Allinson (London, United Kingdom), S. Chotirmall (Singapore, Singapore), J. Wedzicha (London, United Kingdom)
| |